EA200970692A1 - METHODS OF IMPROVING THE STABILITY OF STEROID DERIVATIVES - Google Patents

METHODS OF IMPROVING THE STABILITY OF STEROID DERIVATIVES

Info

Publication number
EA200970692A1
EA200970692A1 EA200970692A EA200970692A EA200970692A1 EA 200970692 A1 EA200970692 A1 EA 200970692A1 EA 200970692 A EA200970692 A EA 200970692A EA 200970692 A EA200970692 A EA 200970692A EA 200970692 A1 EA200970692 A1 EA 200970692A1
Authority
EA
Eurasian Patent Office
Prior art keywords
stability
improving
methods
steroid derivatives
steroid
Prior art date
Application number
EA200970692A
Other languages
Russian (ru)
Inventor
Джозеф Подольски
Original Assignee
Репрос Терапьютикс Инк.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Репрос Терапьютикс Инк. filed Critical Репрос Терапьютикс Инк.
Publication of EA200970692A1 publication Critical patent/EA200970692A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C225/00—Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones
    • C07C225/22—Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones having amino groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/136—Amines having aromatic rings, e.g. ketamine, nortriptyline having the amino group directly attached to the aromatic ring, e.g. benzeneamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/04—Drugs for genital or sexual disorders; Contraceptives for inducing labour or abortion; Uterotonics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/36—Antigestagens
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C221/00—Preparation of compounds containing amino groups and doubly-bound oxygen atoms bound to the same carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/0077—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 substituted in position 11-beta by a carbon atom, further substituted by a group comprising at least one further carbon atom
    • C07J41/0083—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 substituted in position 11-beta by a carbon atom, further substituted by a group comprising at least one further carbon atom substituted in position 11-beta by an optionally substituted phenyl group not further condensed with other rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Предлагаются композиции с улучшенной стабильностью, содержащие фармацевтически приемлемую соль соединения, относящегося к стероидам.Compositions with improved stability are provided comprising a pharmaceutically acceptable salt of a steroid compound.

EA200970692A 2007-01-17 2008-01-03 METHODS OF IMPROVING THE STABILITY OF STEROID DERIVATIVES EA200970692A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US88536307P 2007-01-17 2007-01-17
PCT/US2008/050128 WO2008088935A2 (en) 2007-01-17 2008-01-03 Pharmaceutically acceptable salts of 11- (4-aminophenyl) -19-n0rpregna-4,9 (10) -diene-3, 20-dione derivatives

Publications (1)

Publication Number Publication Date
EA200970692A1 true EA200970692A1 (en) 2010-02-26

Family

ID=39387140

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200970692A EA200970692A1 (en) 2007-01-17 2008-01-03 METHODS OF IMPROVING THE STABILITY OF STEROID DERIVATIVES

Country Status (16)

Country Link
EP (1) EP2125858A2 (en)
JP (1) JP2010516686A (en)
KR (1) KR20090105944A (en)
CN (1) CN101616926A (en)
AR (1) AR064947A1 (en)
AU (1) AU2008206599A1 (en)
BR (1) BRPI0806572A2 (en)
CA (1) CA2674440A1 (en)
CL (1) CL2008000138A1 (en)
CR (1) CR10924A (en)
EA (1) EA200970692A1 (en)
EC (1) ECSP099537A (en)
IL (1) IL199684A0 (en)
MX (1) MX2009007313A (en)
TW (1) TW200835503A (en)
WO (1) WO2008088935A2 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI477276B (en) * 2008-04-28 2015-03-21 Repros Therapeutics Inc Antiprogestin dosing regimens
US8512745B2 (en) 2008-12-08 2013-08-20 Laboratoire Hra Pharma Ulipristal acetate tablets
HUP0900171A2 (en) 2009-03-20 2010-12-28 Richter Gedeon Nyrt Novel crystal form of 17-acetoxy-11›-[4-(dimethyl-amino)-phenyl]-21-metoxy-19-norpregna-4,9-dien-3,20-dione and process for it's preparation
HUP0900487A2 (en) * 2009-08-05 2011-03-28 Richter Gedeon Nyrt Novel crystal polymorphic form of 17-acetoxy-11 -[4-(dimethylamino)phenyl]-21-methoxy-4,9-diene-3,20-dione and process for it's preparation

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA8231B (en) * 1981-01-09 1982-11-24 Roussel Uclaf New 11 -substituted steroid derivatives, their preparation, their use as medicaments, the compositions containing them and the new intermediates thus obtained
US6020328A (en) * 1998-03-06 2000-02-01 Research Triangle Institute 20-keto-11β-arylsteroids and their derivatives having agonist or antagonist hormonal properties
US8044223B2 (en) * 2003-04-04 2011-10-25 Bridge Organics Co. Crystalline 19-norsteroids

Also Published As

Publication number Publication date
CL2008000138A1 (en) 2008-05-16
BRPI0806572A2 (en) 2014-05-06
ECSP099537A (en) 2009-08-28
TW200835503A (en) 2008-09-01
IL199684A0 (en) 2010-04-15
MX2009007313A (en) 2009-07-15
CA2674440A1 (en) 2008-07-24
CR10924A (en) 2009-10-30
EP2125858A2 (en) 2009-12-02
WO2008088935A3 (en) 2009-03-05
AU2008206599A1 (en) 2008-07-24
KR20090105944A (en) 2009-10-07
WO2008088935A2 (en) 2008-07-24
JP2010516686A (en) 2010-05-20
AR064947A1 (en) 2009-05-06
CN101616926A (en) 2009-12-30

Similar Documents

Publication Publication Date Title
NO2018016I2 (en) Niraparib or a pharmaceutically acceptable salt, stereoisomer or tautomer thereof
ATE519764T1 (en) SPIROINDOLINONE DERIVATIVES
ATE495176T1 (en) SPIROINDOLINONE DERIVATIVES
UA107791C2 (en) Pesticidal compositions
EA201070786A1 (en) BENZOFUROPYRIMIDINONES
TN2010000101A1 (en) Fungicidal 2-alkylthio-2-quinolinyloxy -acetamide derivatives
DK2235017T3 (en) Spiroindolinone derivatives as anticancer agents
EA201000544A1 (en) Derivatives of spiroheterocyclic pyrrolidindione, used as pesticides
MX2010005889A (en) Novel thiophene derivatives.
PH12015501993A1 (en) Pyrazole-amide compound and medicinal uses therefor
NO20091395L (en) New thiophene derivatives
UA111640C2 (en) DERIVATIVES [1,2,3] TRIAZOLO [4,5-d] PYRIMIDINE AS A cannabinoid receptor agonist 2
ATE555107T1 (en) 2-AZA-BICYCLO-Ä2,2,1-ÜHEPTAN DERIVATIVES
EA201170703A1 (en) Derivatives of Adamantylbenzamide
RS52255B (en) Nalmefene hydrochloride dihydrate
DE602008005634D1 (en) 1,1,1-trifluoro-2-hydroxy-3-phenylpropane derivatives
TW200942524A (en) Novel aminomethyl benzene derivatives
RS53586B1 (en) Deoxyactagardine derivatives
EA201100612A1 (en) NEW DERIVATIVES 2-AMIDOTHIADIAZOLE
EA201490761A1 (en) R (+) - N-Formylpropylglycinone
CA2904820C (en) Pyridinylpyrazoloquinoline compound
EA201370149A1 (en) ANTAGONISTS RECEPTOR
MA32834B1 (en) Aminocyclopentaneicarboxamide 3 acts as a shimokin receptor modulator
EA201001882A1 (en) HYDROXYLICATED THYENOPYRIMIDINONES AS ANTAGONISTS OF RECEPTOR-I MELANINC-CENTERING HORMONE
CO6341557A2 (en) NITROGEN DERIVATIVES OF PANCRATISTATINE